However, we found that expression of FMR1 and HNRNPA2B1 were not correlated with the overall survival in bladder cancer patients based on TCGA-BLCA dataset, who were not treated with immunotherapy (Supplementary Figure S6). The gene discussed is HNRNPA2B1; the disease is bladder transitional cell carcinoma.